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SUMMARY
The discovery of microRNA (miRNA) sorting into extracellular vesicles (EVs) revealed a novel 
mode of intercellular communication and uncovered a link between cellular endomembrane 
compartments and small RNAs in EV-secreting cells. Using a two-step ultracentrifugation 
procedure to isolate EVs released by T cells, we found that 45% of tRNA fragments (tRFs), but 
fewer than 1% of miRNAs, were significantly enriched in EVs compared with the corresponding 
cellular RNA. T cell activation induced the EV-mediated release of a specific set of tRFs derived 
from the 5′ end and 3′-internal region of tRNAs without variable loops. Inhibition of EV 
biogenesis pathways specifically led to the accumulation of these activation-induced EV-enriched 
tRFs within multivesicular bodies (MVBs). Introducing antisense oligonucleotides to inhibit these 
tRFs enhanced T cell activation. Taken together, these results demonstrate that T cells selectively 
release tRFs into EVs via MVBs and suggest that this process may remove tRFs that repress 
immune activation.
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In Brief
Chiou et al. show that T cells release extracellular vesicles that carry RNA cargo enriched in tRNA 
fragments. Immune activating signals enhance multivesicular body formation and the secretion of 
vesicles containing specific tRNA fragments. Within cells, these tRNA fragments inhibit T cell 
activation and cytokine production.
INTRODUCTION
Extracellular vesicles (EVs) that carry extracellular RNAs (ex-RNAs) are generated from 
different intracellular origins. Microvesicles are assumed to be released directly from 
budding of the plasma membrane, whereas exosomes originate from the endosomal 
compartment and are released upon fusion of multivesicular bodies (MVBs) with the plasma 
membrane (Colombo et al., 2014). The encapsulation of exRNAs within vesicles protects 
them from degradation, making them stable constituents of body fluids. Moreover, exosome-
associated CD47 inhibits phagocytosis, increasing retention in circulation (Kamerkar et al., 
2017). These properties of exRNAs and their carriers have been exploited for biomarker 
discovery, and they allow exRNAs to mediate communication between exosome secreting 
cells and recipient cells (Tkach and Thery, 2016). In addition, the exosome biogenesis 
pathway modulates microRNA (miRNA) silencing activity through the association of 
miRNA effector proteins with MVBs (Gibbings et al., 2009).
T cells are a robust source of EVs containing small RNAs. T-cell-expressed miRNAs are 
associated with EVs and increase in the serum of immunized mice and humans (de Candia et 
al., 2013, 2014), while cellular miRNAs are globally downregulated upon T cell activation 
(Bronevetsky et al., 2013). Exosome secretion is important for proper immune function, as 
Rab27 deficiency modulates inflammatory responses and inhibits chronic inflammation in 
mice (Alexander et al., 2017; Okoye et al., 2014). Target cell killing by cytotoxic T cells 
involves the activation-induced fusion of Rab7-containing cytotoxic granules with the 
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plasma membrane in a Rab27-dependent manner (Daniele et al., 2011; de Saint Basile et al., 
2010). The fusion of MVBs with the plasma membrane in may be regulated in a similar 
manner to control exRNA release in exosomes. For these reasons, T cells are a good model 
for investigating signal-regulated mechanisms of RNA packaging into exosomes and how 
this process affects their biological activity in source and recipient cells.
tRNA fragments (tRFs) are generated through endonucleolytic cleavage of tRNAs 
(Gebetsberger and Polacek, 2013). They are among the most prevalent small RNA species 
detected in exRNA, and in cells they rank second in abundance only to miRNAs (Lee et al., 
2009). Early studies detected tRFs in the urine of cancer patients (Borek et al., 1977; Speer 
et al., 1979), raising the possibility that tRFs may be oncogenic and that they may be 
actively released into body fluids. tRFs can be transferred from epididymosomes to sperm, 
epigenetically transmitting information about paternal diet and metabolism to offspring 
(Sharma et al., 2016). tRFs also impact a number of functions in somatic cells, including cell 
proliferation, cancer progression, and the activity of endogenous retroelements (Goodarzi et 
al., 2015; Maute et al., 2013; Schorn et al., 2017). However, their secretion and biological 
effects in T cells remain unexplored.
In the present study, we analyzed EVs rigorously separated from ribonucleoprotein 
aggregates in cell culture supernatants of activated T cells. RNA sequencing showed that 
compared with cellular RNAs, tRFs were enriched in EVs more than any other class of 
RNA, which is consistent with studies in cell lines (Baglio et al., 2015; Koppers-Lalic et al., 
2014; Li et al., 2013; Liao et al., 2014; Tosar et al., 2015). We further identified specific sets 
of tRFs whose release via EVs is enhanced by T cell activation and showed that blocking 
tRF release by neutral sphingomyelinase (nSMase) inhibitor increased the cellular levels of 
these activation-induced EV-enriched tRFs but not other activation-independent EV-enriched 
tRFs. Subcellular fractionation further showed that nSMase inhibitor treatment specifically 
led to the accumulation of these activation-induced EV-enriched tRFs within the Rab7-
containing compartments, suggesting that these tRFs were released via MVB sorting. T cells 
transfected with antisense oligonucleotides against these tRFs displayed enhanced T cell 
activation. These results indicate that activated T cells utilize EV biogenesis pathways to 
selectively secrete tRFs that can repress T cell activation.
RESULTS
Purified T Cell EVs Contain Intact Extracellular Small RNA Species
To establish an experimental system for investigating the effects of activating signals on 
exRNA biogenesis, we isolated EVs secreted by primary T cells stimulated with antibody 
agonists of antigen and costimulatory receptors (anti-CD3 and anti-CD28) (Figure S1A). 
After 3 days in these culture conditions, approximately 60% of in vitro activated T cells 
remain alive, and they uniformly upregulate CD44 and downregulate CD62L (Figure S1B). 
Since so many T cells die during activation, we expected that intracellular contents passively 
released from dead cells would contaminate EVs secreted by live cells. To separate EVs 
from contaminating particles, we used a two-stage purification procedure to isolate EVs. 
First, large contaminating cells and cellular debris were removed from the media by 
successive low and medium speed centrifugation, and EVs and other small particles were 
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pelleted by ultracentrifugation at 100,000 × g. Second, to eliminate non-vesicle 
contaminants, the 100,000 × g pellet was resuspended in 80% sucrose buffer, overlaid with 
lower concentrations of sucrose buffer, and ultracentrifuged again to float vesicles into the 
less dense sucrose layers (Figure 1A).
Fractions of these gradients were collected for further analysis. Several independent lines of 
evidence indicated that fraction 3 contained EVs, while fraction 6 was dominated by 
degraded RNA and/or protein aggregates. First, fraction 3 was composed of 34% to 52% 
sucrose, corresponding to a density of 1.15 to 1.20 g/ml, the known density range of 
exosomes (Théry et al., 2006). Second, fraction 3 was highly enriched in the microvesicle 
and exosome protein markers Arf6 and Tsg101 (Figure 1B). Ago2 and GW182 proteins 
involved in miRNA function were present but not enriched in EVs. The total protein quantity 
in fraction 3 was similar to that of T cell lysates made from 100-fold fewer cells (Figure 1B, 
bottom; compare fraction 3 of 100,000 × g pellet from 12 × 106 cells versus cell lysate from 
0.12 × 106 cells), indicating that activated T cells secreted at least 1% of their cellular 
protein content in an EV-rich exudate. Fraction 6 contained even more total protein and was 
non-selectively enriched for all proteins tested by immunoblotting, suggesting that it was 
dominated by dense protein aggregates that remained at the bottom of the sucrose gradient.
Finally, RNA analyses showed that fraction 3 contains intact exRNA species. Bioanalyzer 
analysis detected intact 28S and 18S rRNA in fraction 3 but not in fraction 6, despite the 
latter’s higher overall RNA content (Figure 1C). Compared with cells, both fractions were 
enriched in smaller RNA species. PAGE separation of 50–300 nt RNAs further demonstrated 
that fraction 3 contained intact 5.8S and 5S rRNAs and tRNAs, whereas fraction 6 was 
dominated by apparently randomly fragmented RNAs. Although full-length rRNAs were 
detected in EV fractions, they were not enriched in EV fractions compared to cellular RNA, 
consistent with previous reports (Wei et al., 2017). qPCR showed that intact miRNAs were 
also much more abundant in fraction 3 than in fraction 6 (Figure 1D). These results suggest 
that the various exRNA species in fraction 3 are protected from degradation by 
encapsulation within EVs. To test this possibility, we treated fraction 3 or fraction 6 with 
RNase A in the presence or absence of the vesicle-disrupting detergent Triton X-100. For 
fraction 3, RNase treatment did not dramatically alter miRNA or other exRNA species 
detection unless Triton X-100 was present (Figure 1E, top). By contrast, RNase treatment of 
fraction 6 with RNase A dramatically reduced the detection of exRNAs even in the absence 
of Triton X-100 (Figure 1E, bottom). All together, these data show that in vitro activated T 
cells release EVs that contain and protect exRNAs and that our purification procedure 
separates these EVs from RNA and/or protein aggregates that also accumulate in the culture 
media.
tRFs Are Enriched in T Cell EVs
To identify specific small RNAs that were enriched in bona fide T cell EVs free from 
aggregate contamination, we performed sequencing of small (~15–31 nt) RNA libraries 
prepared from EVs (F3), aggregates (F6), and activated T cells (Figure 1B). To reduce bias 
in small RNA library preparation, we modified the 5′ and 3′ ligation adaptors with five 
random bases added to the 3′ end and 5′ end, respectively (Fuchs et al., 2015). Greater than 
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70% of sequence reads from cell libraries mapped to the genome, compared to 62% from 
EVs and 55% from aggregates (Figure S2A), consistent with lower mapping rates for EV 
libraries in the previous study (Cha et al., 2015).
Classifying the sequenced RNAs revealed several distinct features of the composition of 
small RNAs and RNA fragments in T cells, EVs, and aggregates. First, RNA fragments 
derived from larger RNA classes, including protein coding mRNAs and long intergenic 
noncoding RNAs (lincRNAs), accounted for about 50% of the total reads in all libraries, and 
their composition was similar among all samples (Figure 2A). Second, miRNAs were 
depleted compared to cellular RNA, slightly in EVs but greatly in aggregates (Figure 2A). 
This is consistent with qPCR results that detected much higher miRNA abundance in EVs 
than in aggregate fractions (Figure 1D). Third, EVs and aggregates differ greatly in their 
composition of other RNA classes. In particular, tRFs were specifically enriched in EVs, 
whereas aggregates contained more small nucleolar RNA (snoRNAs) and small nuclear 
RNA (snRNAs) (Figure 2B).
We further classified tRFs into five groups derived from different parts of full-length tRNAs: 
the 5′ end (5′tRF), 3′ end (3′CCA-tRF), 5′-internal region (5′i-tRF), 3′-internal regions 
(3′i-tRF), and central internal region (i-tRF) (Figure 2C). In each group, longer tRFs (26 to 
31 nt) and shorter tRFs (14 to 25 nt) were classified as L-tRF and tRF, respectively. We 
found that 5′tRFs and 3′i-tFRs were enriched, but 3′CCA-tFRs were depleted in EVs 
compared to cellular small RNAs (Figure 2D). Analysis of tRF read length revealed that 18–
21 nt 5′tRFs were dominantly enriched in EVs, while 17–18 and 22 nt 3′CCA-tRF reads 
were significantly depleted (Figure S2B). These data indicate that specific tRNA cleavage 
events generate tRFs that are preferentially released or retained in cells.
Detailed comparison of all RNA species in EVs and cells further elucidated the specificity 
ofTcell release of tRFs within EVs. As a fraction of all sequenced RNAs, only one miRNA 
(miR-150) exhibited EV enrichment (EE) as measured by the ratio of RNA reads in EVs 
versus cells. In contrast, 45% of tRFs showed at least 1.5-fold EE (Figure 2E; Table S1). 
Among the subgroups of tRFs, 5′tRFs were the most uniformly and highly enriched in EVs. 
98% of all 5′tRFs displayed at least 1.5-fold EE, with some enriched as much as 10-fold 
(Figure 2F). In comparison, EE greater than 1.5-fold was observed for just 2%, 26%, 29%, 
and 36% of 3′L-tRF/i-tRF, 5′i-tRF, 5′L-tRF, and 3′i-tRF, respectively. Although 53% of 
3′CCA-tRFs exhibited at least 1.5-fold EE (Figure 2F), the 3′CCA-tRF derived from tRNA-
Ala-TGC that accounted for 10% of all tRF reads were depleted in EVs, resulting in fewer 
total reads of 3′CCA-tRFs in EVs compared to cells (Figure 2D). Taken together, our results 
revealed that tRFs were more significantly enriched in EVs than were miRNAs and other 
small RNAs and that 5′tRFs and select other tRFs were preferentially exported into EVs 
secreted from activated T cells.
Selective Signal-Regulated tRF Release by T Cells
To determine whether T cell activation modulates the export of tRFs, we isolated EVs 
secreted from resting T cells using the same two-step procedure (Figure S3A). Resting T 
cells were much smaller than stimulated T cells (Figure S3B), and 3.3-fold more resting 
cells were required to obtain the same yield of EVs (by protein content) as was obtained 
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from stimulated cells (Figure 3A; compare 40 million resting versus 12 million stimulated T 
cells). However, the efficiency of EV production was similar under resting and stimulated 
conditions. Once again, approximately 1% of the protein yield from cell lysates was released 
into the EV fraction during culture under resting conditions (Figure 3B; compare EVs from 
40 × 106 cells to cell lysate from 0.4 × 106 cells). Small RNAs under 150 nt and the 
exosome protein markers Tsg101 andCD81 were less enriched in EV fractions under resting 
conditions (Figures 3B and S3C), whereas EV fractions contained similar amounts of β-
actin and total protein under resting conditions and stimulated conditions. This indicates that 
fewer exosomes were secreted and other types of co-purifying EVs that contained lower 
levels of exosomal markers and small RNAs may be more predominantly released under 
resting conditions. Small RNA sequencing showed that miRNAs were similar, but tRFs 
showed less EE under resting conditions (Figures S3D and S3E). In particular, 5′tRF and 
3′i-tRF reads were less enriched, and 3′CCA-tRF reads were less depleted from EV 
fractions under resting conditions compared to stimulated conditions (Figure 3C).
To identify the specific tRFs that exhibit activation-induced EE, we directly compared 
sequencing data for EVs and cells under stimulated and resting conditions. Among the 
5′tRFs, 5′L-tRFs, and 5′-i-tRFs with ≥ 1.5-fold EE in stimulated conditions, large 
majorities (77%, 98%, and 69%, respectively) exhibited at least 1.5-fold greater EE in 
stimulated T cell cultures as compared to their EE in resting T cells. In contrast, 3′CCA-
tRFs displayed uniformly higher EE in resting conditions, and only 48% of 3′i-tRFs were 
more EV enriched in stimulated conditions (Figure 3D; Table S2). There are two structural 
types of 3′i-tRF, as follows: hairpin fragments (3′i-tRF-H) and linear fragments (3′i-tRF-L) 
that derive from tRNAs with and without variable loops, respectively (Figure 2C). 63% of 
the linear 3′i-tRF-L, but none of the haripin 3′i-tRF-H fragments, showed greater EE in 
stimulated conditions (Figure 3E). These results indicate that the positions within parent 
tRNAs and the secondary structures of internal tRFs correlate with selective release into EVs 
in response to T cell activation. tRFs derived from the 5′ end of tRNAs and from internal 
regions without hairpin structures exhibited EE that is enhanced upon T cell activation.
Examination of read alignments to individual representative tRNAs illustrate these regional 
patterns of EE and revealed that tRFs derived from the same tRNA can display different 
types of EE (Figures 4A and S4A). For simplicity, we classified tRFs into the following 
three categories: activation-induced EE, activation-independent EE, and not enriched. 5′tRF 
derived from the tRNAs Leu-TAA and Leu-TAG showed activation-induced EE, whereas 
3′i-tRF-H from tRNA Leu-TAA exhibited activation-independent EE. Oligo(dT) qRT-PCR 
detected both tRFs and full-length tRNA in Poly(A) polymerase treated cellular RNA, as 
shown by gel electrophoresis of PCR products in the exponential phase of amplification 
(Figure 4B). However, since EV did not contain detectable full-length tRNA, this assay 
could be used to measure the relative abundance of tRFs in EVs from resting and activated T 
cells. Activation-induced EV-enriched tRFs were increased by 4- to 6-fold in EVs following 
T cell stimulation, whereas activation-independent EV-enriched tRFs were only ~2-fold 
more abundant in EVs from resting versus stimulated T cells (Figure 4C). RNase treatment 
with and without Triton X-100 indicated that these tRFs were encapsulated within EVs 
(Figure 4D).
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We designed stem-loop qRT-PCR assays that reliably distinguish tRFs from their 
corresponding full-length tRNAs (Figures S4B and S4C) and used them to further confirm 
that all three of these EV-enriched tRFs were enriched in EV compared to cellular RNA 
(Figure 4E). Moreover, the difference in tRF abundance in EV and cellular RNA was greater 
in stimulated conditions than resting conditions for activation-induced EV-enriched 5′tRFs 
Leu-TAA and Leu-TAG but not for the activation-independent EV-enriched 3′i-tRF Leu-
TAA. These data validate specific abundant tRFs that were differentially enriched in EVs 
produced by T cells in response to activating antigen and costimulatory receptor signals.
Activation-Induced nSMase-Dependent MVB Formation and tRF Downregulation
We hypothesized that activation-induced EV release may lead to the downregulation of 
cellular tRFs through MVB-mediated EV biogenesis pathways. Exosomes are released when 
cellular MVBs fuse with the plasma membrane, releasing intraluminal vesicles and their 
associated cargo. This process is regulated by ESCRT (endosomal sorting complexes 
required for transport) complexes and the activity of nSMase (Colombo et al., 2014). The 
nSMase inhibitor GW4869 (Luberto et al., 2002) repressed EV production by activated T 
cells, as indicated by dose-dependent reductions in the recovery of EV proteins and RNA in 
EV fractions (Figures 5A–5C). Total EV RNA recovery was reduced to about 50% of 
control in GW4869 treated cells, similar to the decrease of TfR and Arf6, but less than the 
95% reduction of the restricted exosomal marker Tsg101 (compare Figure 5B and Figure 
5C). These data indicate that GW4869 repressed the release of exosomes more than other 
types of EVs produced by activated T cells.
We compared the small RNA species in cells and EV fractions from T cells treated with 
GW4869 and DMSO vehicle alone by sequencing. GW4869 treatment did not significantly 
alter the overall distribution of broad classes of small RNAs in cells or EV fractions (Figures 
S5A–S5C). However, the EE of tRFs was altered by GW4869 treatment. 40% of all 
activation-induced EV-enriched tRFs and 63% of activation-independent EV-enriched tRFs 
exhibited 1.5-fold or more reduction in EE in GW4869 treated cells, compared with just 
13% of non-enriched tRFs (Figure 5D; Table S2). Oligo(dT) qRT-PCR confirmed that 
GW4869 reduced the abundance of EV-enriched tRFs in EVs by 20%–50% at low 
concentration (10 μM) and by 60%–80% at high concentration (20 μM) (Figures 5E and 5F). 
Quantifying gel bands corresponding to tRF qRT-PCR products from cellular RNA indicated 
that activation-induced EV-enriched tRFs accumulated in cells upon GW4869 treatment 
more than activation-independent EV-enriched tRFs (Figures 5E and S5D). Stem-loop qRT-
PCR confirmed that GW4869 treatment reduced both activation-induced and activation-
independent EV-enriched tRF abundance in EVs while selectively increasing the cellular 
abundance of activation-induced EV-enriched tRFs (Figure 5G). Thus, nSMase activity is 
required for EV-enriched tRF enrichment in EVs and to prevent accumulation of activation-
induced EV-enriched tRFs in activated T cells.
GW4869 represses not only the release of exosomes via MVB but also microvesicles that 
bud directly from the plasma membrane (Menck et al., 2017). To further probe the pathway 
of tRF release by T cells, we analyzed their subcellular localization by cellular organelle 
fractionation. Previous studies have reported that the 15,000 × g pellet of homogenized cells 
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contains active MVBs that can sort proteins or RNAs into intraluminal vesicles (Shurtleff et 
al., 2016). We obtained 15,000 × g pellets from homogenized T cells and then further 
fractionated them by Opti-prep gradient centrifugation (Figure 6A). In resting T cells, the 
late endosome protein Rab7 was enriched in fractions (6 and 7) that contained no detectable 
CD81 (Figure 6B). CD81 is an exosome marker that can appear on the plasma membrane 
and endomembranes in lymphocytes. By contrast, in activated T cells, Rab7 was enriched in 
fractions (4,5, and 6) with substantial CD81 protein. These results indicate that CD81 may 
be more actively incorporated into Rab7-containing MVBs in activated T cells. Notably, we 
also observed greater enrichment of CD81 in EV fractions from activated compared with 
resting T cell supernatants (Figures 3A and 3B).
The lower-density Rab7- and CD81-containing membrane fractions may represent MVBs 
that are intracellular intermediates of exosome biogenesis. Consistent with this 
interpretation, GW4869 treatment of stimulated T cells shifted the enrichment of Rab7 back 
to the higher-density fractions 6 and 7. GW4869 reduces the formation of intraluminal 
vesicles in MVBs, which may lead to increased MVB density (Trajkovic et al., 2008). These 
high-density Rab7-containing fractions also contained CD81, suggesting that GW4869 
blocked MVB maturation after incorporation of CD81 and potentially RNA cargo as well. 
Oligo(dT) RT-PCR detected both full-length tRNAs and tRFs in key cellular Optiprep 
gradient fractions (Figure S6). Therefore, we used stem-loop qRT-PCR to quantify tRFs 
(Figure 6C). Under resting conditions, both activation-independent and activation-induced 
EV-enriched tRFs were concentrated in cytosolic and high-density Rab7-containing fractions 
(Figure 6C, left panel). These tRFs were mainly restricted to the cytosolic fractions from 
stimulated T cells (Figure 6C, middle panel). Increased MVB formation and EV release may 
efficiently reduce the burden of EV-enriched tRFs in Rab7-containing endomembrane 
compartments in activated T cells. Consistent with this possibility, GW4869 treatment 
induced dramatic accumulation of activation-induced EV-enriched tRFs (and to a lesser 
degree, the activation-independent EV-enriched 3′i-tRF from Leu-TAA) in high-density 
Rab7- and CD81-containing fractions as compared to cytosolic fractions (Figure 6C, right 
panel). Taken together, these results indicate that T cell activating signals induce functional 
MVB formation and constitutive removal of activation-induced EV-enriched tRFs.
Activation-Induced EV-Enriched tRFs Inhibit T Cell Activation
We hypothesized that signal-regulated release of tRFs in EVs may serve as a means to 
export cellular tRFs that could alter T cell activation. To test the functional impact of these 
tRFs, we transfected T cells with 2′-o-methylated oligonucleotides antisense to specific 
abundant tRFs (Table S2) on day 1 of activation and then analyzed transfected cells on day 
3. Activated T cells upregulate CD44, downregulate the lymph node homing molecule 
CD62L, and produce cytokines such as interleukin-2 (IL-2). Antisense oligos against the 
activation-independent EV-enriched 3′i-tRF derived from tRNA Leu-TAA and tRNA Ser-
GCT did not affect the downregulation of CD62L or the upregulation of CD44 (Figures 7A–
7C). However, antisense oligos against the activation-induced EV-enriched 5′tRFs derived 
from both tRNA Leu-TAA and tRNA Leu-TAG enhanced cell activation, as shown by 
decreased CD62Lhi cells and a corresponding increase in the frequency of fully activated 
CD44hiCD62Llo cells (Figures 7A–7C). We measured cytokine production by flow 
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cytometry following restimulation with PMA (phorbol 12-myristate 13-acetate) and 
ionomycin (Figures 7D and 7E). IL-2 production was enhanced in T cells transfected with 
antisense oligo against either activation-induced EV-enriched tRF but neither of the 
activation-independent EV-enriched tRFs. These transfected T cells expressing more IL-2 
and other activation markers also displayed lower viability in culture (Figure S7). These 
observations may be linked, as IL-2 sensitizes T cells to activation-induced apoptotic cell 
death (Marks-Konczalik et al., 2000). These results suggest that T cells engage EV 
biogenesis pathways to dispose of tRFs that can inhibit their activation and cytokine 
production.
DISCUSSION
Our results show that T cells release specific sets of tRFs within EVs through their 
association with MVBs in a signal-regulated manner. By rigorously separating 
contaminating RNA and/or protein aggregates from EVs, we found that tRFs, but not 
miRNAs, are enriched in T-cell-derived EVs relative to all other cellular small RNA species. 
Specific classes of tRFs distinguished by their location in the parent tRNA and by tRNA-
specific structural features were preferentially released in EVs. For some of these classes, 
their release was regulated during T cell activation. tRFs enriched in EVs in an activation-
induced manner were mostly derived from tRNA 5′ ends, 5′-internal regions, and 3′-
internal regions without variable loop hairpins. In contrast, tRFs derived from tRNA 3′ ends 
and 3′-internal regions with variable loop hairpins were frequently enriched in EVs from 
activated T cells similarly or even less than those produced by resting T cells. These patterns 
of EV release corresponded with differences in the accumulation of tRFs within activated T 
cells treated with the nSMase inhibitor GW4869, which inhibits EV biogenesis pathways. 
GW4869-treated activated T cells accumulated activation-induced EV-enriched tRFs, but not 
activation-independent EV-enriched tRFs within high-density fractions containing Rab7 and 
the exosome marker CD81, suggesting that these tRFs are released through an MVB-
mediated EV biogenesis pathway. EVs released from activated T cells also contained more 
CD81 than EVs from resting T cells, further indicating that signal-regulated exosome 
production contributes to tRF secretion. Antisense oligos directed against activation-induced 
tRFs increased T cell activation. Taken together, these findings imply that secretion via 
exosomes and other EVs is a mechanism whereby T cells rapidly remove tRFs through 
endomembrane compartments to prevent them from engaging cytosolic targets that mediate 
T cell activation.
Global miRNA turnover and selective downregulation also occurs during T cell activation 
(Bronevetsky et al., 2013). However, in contrast to tRFs, miRNAs were present but not 
enriched in EVs released by T cells. This finding is consistent with previous analyses of the 
RNA composition of exosomes secreted by B cells, stem cells, and glioblastoma, 
esophageal, and breast cancer cells (Baglio et al., 2015; Koppers-Lalic et al., 2014; Li et al., 
2013; Liao et al., 2014; Tosar et al., 2015). Ago2 protein was also not enriched in T cell EVs 
compared to cellular protein, indicating that Ago2-miRNA complexes are not selected for 
sorting into EVs. In isogenic cell lines differing only in KRAS status, MVB association and 
exosomal release of Ago2 and miRNAs was decreased by an activating KRAS mutation 
(McKenzie et al., 2016). Since Kras is activated by T cell receptor signaling (Ebinu et al., 
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2000), it is possible that activated Kras represses exosomal release of miRNAs associated 
with Ago2 in T cells and in a variety of stem and cancer cell lines. This possibility is 
consistent with the report that few miRNAs are enriched in exosomes secreted by the Jurkat 
T cell line and that these exosomal miRNAs are not associated with Ago2 but instead 
interact with another RNA binding protein, hnRNPA2/B1 (Villarroya-Beltri et al., 2013). 
Coordinated mechanisms of cellular small RNA repertoire remodeling may be an important 
feature of T cell activation and immune responses.
Among small RNAs, tRFs are second only to miRNAs in their abundance, and they have 
been shown to regulate critical cellular functions (Lee et al., 2009; Thompson and Parker, 
2009). Although tRF species have been shown to be abundant in exosomes in several 
studies, their biogenesis and function as exRNAs are relatively understudied. Our 
comprehensive analysis of tRFs in T cells and their secreted EVs showed that almost all 
5′tRFs, but only a select few derived from other regions of tRNAs, are enriched in EVs. 
Three types of tRFs derived the 5′ terminus of tRNAs have been classified according to 
their length: 5′halves (31–33 nt), 5′L-tRFs (26–31 nt), and 5′tRF (less than 26 nt). Specific 
5′halves repress protein translation by targeting eukaryotic translation initiation factors 
(Ivanov et al., 2011) and modulate the formation of stress granules to inhibit protein 
synthesis (Emara et al., 2010). 5′L-tRFs derived from tRNA Gly-GCC are transferred from 
the epididymis to sperm to regulate endogenous retroelements (Sharma et al., 2016). In 
contrast to 5′halves and 5′L-tRFs, 5′tRFs have no hairpin structures. Their specific and 
prominent activation-induced EE suggest that 5′tRFs may regulate different cellular 
processes that are associated with membrane compartments, allowing their rapid removal 
through EV-biogenesis pathways.
The positional and structural patterns apparent in tRFs that undergo activation-induced EV 
release indicates that mechanisms that sort specific tRFs into EVs may be coupled to tRNA 
processing pathways. Dicer and Angiogenin (ANG) cleave the D-loops, T-loops, and 
anticodon loops of mature tRNAs (Cole et al., 2009; Fu et al., 2009). ANG is a candidate 
mediator of tRF processing and sorting into EVs, possibly in collaboration with the RNA 
binding protein YBX1. ANG is a secreted protein present at high concentration in blood 
plasma (Barcena et al., 2015) and is itself enriched in exosomes (Wei et al., 2017). YBX1 
associates with miR-223 and packages this miRNA into exosomes (Frye et al., 2009; 
Shurtleff et al., 2016). YBX1 also interacts with a specific set of tRFs (Goodarzi et al., 
2015). Some of these tRFs could be derived from ANG cleavage. Most YBX1-associated 
tRFs are derived from 5′ internal regions or central regions that include the anticodon loops 
of tRNAs (Goodarzi et al., 2015). Both miR-223 and some of the known YBX1-associated 
tRFs were enriched in EVs in an activation-induced manner in T cells, making YBX1 a 
candidate for tRF sorting into EVs upon T cell activation. tRNA synthetases that associate 
with ceramide or the lysosome may also play a role in the observed selectivity of tRF 
processing and secretion (Bidlingmaier et al., 2016; Choi et al., 2017; Han et al., 2012).
Our findings indicate that removal of cellular tRFs via sorting into MVBs and EVs may be 
an important mechanism to avert inhibitory functions of tRFs during T cell activation. 
However, tRFs in secreted EVs may be actively transferred among cells, allowing them to 
mediate intercellular RNA communication. These uniquely regulated exRNA species may 
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also have utility as biomarkers of immune activity and disease processes. Compared with 
miRNAs, which are ubiquitous in almost all cell types, 5′tRFs as a class appear to be 
selectively abundant in hematopoietic tissues (Dhahbi, 2015). In summary, our data show 
that tRFs are functionally active small RNAs that are dynamically regulated by differential 
intracellular compartmentalization and release within EVs in response to T cell activating 
signals.
STAR★METHODS
CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be 
fulfilled by the Lead Contact, K. Mark Ansel (mark.ansel@ucsf.edu).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mice—C57BL/6J were purchased from Jackson Laboratory and bred in specific pathogen-
free conditions in the Animal Barrier Facility at the University of California, San Francisco. 
Male and female mice were euthanized with CO2 at 4-7 weeks of age for spleen and lymph 
node removal. All animal experiments were approved by the Institutional Animal Care and 
Use Committee of the University of California, San Francisco.
METHOD DETAILS
CD4+ T cell stimulation and culture—Naive CD4+ T cells from spleen and lymph 
nodes of mice were purified by magnetic bead selection (Invitrogen) and used in all 
experiments. For stimulated conditions, naive T cells were stimulated with plate-bound anti-
CD3 (2.0 μg/ml) and soluble anti-CD28 (0.5 μg/ml) in the presence of 10 units/mL IL2 
(National Cancer Institute) for ~60 hr at initial cell density of ~1 × 106 cells/ml. After 
stimulation, the cell density of live cells was similar to the initial density of the naive cells 
(~1 × 106 cells/ml) since not only cell proliferation but also cell death occurs during 
stimulation. For resting conditions, T cell cultures that were stimulated for ~48 hr were 
resuspended and diluted with 3 volumes of media containing 10 units/ml IL2. After 
expansion for ~24 hr, cells were spun down and resuspended in EV-free media containing 10 
units/ml IL2 for 48 hr at initial cell density of ~2 × 106 cells/ml, which then becomes ~4 × 
106 cells/ml after 48 hr-resting in IL2-containing media. Cells grown for exosome 
production were incubated in EV-free medium produced by ultracentrifugation at 100,000 × 
g (28,000 RPM) for 18 hr using an SW-28 rotor (Beckman Coulter). All T cell culture was 
done in DMEM high-glucose media supplemented with 10% FBS and other chemicals as 
previously described (Steiner et al., 2011).
Exosome/EV purification—Cell culture supernatant and T cells were harvested together 
by gently pipetting T cells sediment in the bottom of the plate with the conditioned medium. 
The collected medium containing both T cells and cell culture supernatant was centrifuged 
for 10 min at 300 × g. The resulting cell pellet was used for cell lysate, RNA preparation or 
subcellular fractionation and the resulting supernatant was further centrifuged for 20 min at 
2000 × g to remove cellular debris. To remove microvesicles, the supernatant collected from 
2000 × g spin was centrifuged for 30 min at 10,000 × g. The resulting supernatant 
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containing both exosomes, other types of EVs and RNA and/or protein/membrane 
complexes or aggregates was further subjected to ultracentrifugation at 100,000 × g for 2 hr. 
To separate EVs from the contaminating aggregates, the resulting crude EV pellet was 
resuspended in 100 μL PBS and 1 mL 90% sucrose buffer (final sucrose concentration = 
82%), which was then overlaid with 11 layers of 1 mL sucrose buffer in order from high to 
low concentrations, including buffers containing 70%, 64%, 58%, 46%, 40%, 34%, 28%, 
22%, 16%, and 10% of sucrose. The resulting 12 mL sucrose gradient was subjected to 
ultracentrifugation at 100,000 × g for 18 hr. Six fractions, each of which is 2 ml, were 
collected from top to bottom and resuspended in 9 mL PBS, which were then further 
centrifuged at 100,000 × g for 1 hr. The resulting supernatants were poured out and the 
pellets were resuspended in 50 μL PBS. The third fraction from the top, which contains the 
interface of the 34% and 40% sucrose solutions, should be enriched for EVs. The sixth 
fraction, which contains the interface of the 70% and 82% sucrose solutions, contains 
protein/RNA/membrane aggregates. All sucrose buffers were made with sucrose and PBS.
Qligo(dT) RT-qPCR—Total RNA was extract from EVs by using Trizol LS (Life 
Technologies). For RNase protection assays, EVs were left untreated, treated with 50 μg/ml 
RNase A or treated with RNase A in the presence of 0.1% Triton X-100 (Sigma) for 15 min 
at room temperature. The relative levels of miRNAs or tRFs in EVs were quantified by 
miScript II RT Kit and miSYBR Green PCR Kit (QIAGEN). The miScript II RT Kit added 
poly (A) to the 3′ end of RNAs followed by using oligo(dT) adaptor for the RT reactions. 
The qPCR universal reverse primer was included in the miSYBR Green PCR Kit. The qPCR 
forward primers for miRNAs, U6 snRNA, and 18S rRNA were previously described 
(Bronevetsky et al., 2013). The qPCR forward primers for all tRFs were the full-length tRF 
sequences provided in Figure S4.
Stem loop RT-qPCR—The design of primers, probes and reaction conditions were as 
previously described with the following modifications (Chen et al., 2005; Moltzahn et al., 
2011). TaqMan MicroRNA Reverse Transcription kit (Applied Biosystems) was used for 
reverse transcription reactions. The 7.5 μL RT reactions contained 20 ng of total RNA, 1 × 
RT buffer, 1 mM dNTP, 3.33 U/ìl MultiScribe reverse transcriptase, 0.25 U/ìl RNase 
inhibitor and 50 nM stem-loop RT primer. RT reaction conditions: 16°C for 30 min, 42°C 
for 30 min, and 85°C for 5 min. The 10 μL pre-PCR reactions contained 3 μL RT-product, 1 
× TaqMan Universal PCR master Mix with no AmpErase UNG (Applied Biosystems), 50 
nM forward primer and 50 nM universal reverse primer. Pre-PCR conditions: 95°C for 10 
min, followed by 8 cycles of 95°C for 10 s, and 65°C for 1 min. The 10 μL qPCR reactions 
included 2 μL pre-PCR product, 1 × TaqMan Universal PCR master Mix with no AmpErase 
UNG (Applied Biosystems), 0.2 ìM TaqMan probe (IDT), 1.5 ìM forward primer, and 0.7 
ìM universal reverse primer. qPCR reaction conditions: 95°C for 10 min, followed by 40 
cycles of 95°C for 10 s, and 65°C for 1 min. The universal reverse primer sequence is 
GTGTCGTGGAGTCGGC. The stem-loop RT primer sequence is 
CTCAACTGGTGTCGTG GAGTCGGCAATTCAGTTGAG(X)8. The forward primer 
sequence is ACACTCCAGCTGGGTGGATTTATATC(X)15-16. The TaqMan probe sequence 
is /56-FAM/TTCAGTTGA/ZEN/G(X)8/3IABkFQ/ (PrimeTime qPCR probes, IDT). In all 
sequences, X indicates the tRF-specific sequence shown in Figure S4C.
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Subcellular fractionation—107 cells T cells were washed 3 times in PBS and 
resuspended in 2 volumes of homogenization buffer (400 mM sucrose, 20 mM HEPES, pH 
7.5, 1mM EDTA) with Complete Mini protease inhibitor (Roche) and 1U RNasin 
(Promega). The activated T cells in homogenization buffer were passed ~50 times through a 
22 gauge needle, and resting T cells were passed ~80 times through a 25 gauge needle until 
50%–80% of cells were disrupted, as assessed by trypan blue staining. The homogenized 
cells were then centrifuged at 1,500 × g for 5 min to remove nuclei and the resulting 
supernatant was centrifuged at 15,000 × g for 20 min to spin down large cellular membranes, 
which were then subjected to OptiPrep gradient centrifugation. The OptiPrep gradient was 
made by overlaying 10 layers of 0.4 mL buffer in order from high to low concentration 
(33%, 30%, 27%, 24%, 21%, 18%, 15%, 12%, 9% and 6%) of OptiPrep. All OptiPrep 
solutions were made in buffer containing 50 mM HEPES, 78 mM NaCl, 4 mM MgCl2 and 
8.4 mM CaCl2 and 10 mM EDTA. The 15,000 × g pellet fraction was resuspended in 100 μL 
PBS and added on the top of the OptiPrep gradients, and centrifuged at 40,000 rpm for 45 
min using a SW55 rotor (Beckman Coulter). Seven fractions of 600 μL each were collected 
from top to bottom. 200 μL of each fraction was extracted in 700 μL Trizol (Invitrogen) for 
RNA purification and 400 μL of each fraction was further concentrated by StrataClean Resin 
(Agilent Genomics) for western blot analysis. Briefly, 10 μL of StrataClean Resin was added 
to each fraction followed by incubation at 4°C for 1 hr on a rotator mixer. After spinning 
down resin and removing supernatant, 30 μL of 1.5 × Laemmli buffer was added to each 
sample, which was then frozen for at −80°C until use.
Small RNA cDNA library preparation—Barcoded small RNA cDNA libraries were 
prepared as previously described with modifications (Williams et al., 2013). Briefly, to 
reduce ligation bias, 5 random nucleotides were added into the 3′ end of 5′-adaptor and the 
5′end of 3′-adaptors during the oligo synthesis. Barcoded 3′-adaptors were adenylated by 
5′DNA adenylation kit (NEB). 19-nt and 24-nt synthetic oligoribonucleotides that were used 
as size markers were radiolabeled at the 5′ end by T4 PNK (NEB). 10 ng RNA from each 
EV or cell sample and the radiolabeled size markers were ligated separately to 10 μM 
adenylated 3′-adaptor using T4 RNA ligase 2, truncated K227Q (NEB) at 4°C for overnight. 
The 3′-ligation reactions containing EV or cell samples were pooled, ethanol-precipitated 
and loaded into a single lane of a 15% denaturing polyacrylamide gel. The ligation reactions 
containing radiolabeled 19-nt and 24-nt oligos were loaded into the nearby lane to be the 
size markers for cutting the band containing 3′-ligated products of pooled EV and cell 
samples from gels. The RNAs within the cut gel pieces were eluted at 4°C for overnight 
followed by ethanol precipitation. The purified 3′-ligated products were further ligated to 10 
μM 5′-adaptor using T4 RNA ligase 1 (NEB) at 37°C for 1 hr. Ligated small RNAs were 
again cut and purified from a 12% polyacrylamide gel based on the radiolabeled size 
markers. The purified ligated small RNAs were reverse-transcribed using SuperScript III 
(Invitrogen), and amplified by PCR. The PCR products that were in the exponential phase of 
amplification, which is 8-12 cycles in this study, were purified from 2.5% agarose gel 
(Semkem LE agarose, Lonza) using a gel extraction kit (QIAGEN). The gel purification step 
was performed twice to increase the removal of adaptor dimers from ligated small RNAs. 
Except for the five random nucleotides within the 3′ end of 5′-adaptor and the 5′ end of 3′-
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adaptors, all the sequences including 5′-adaptors, barcoded 3′-adaptors, PCR primers were 
the same as those published in the previous studies (Farazi et al., 2012).
Annotation of tRFs from RNA-seq data—The obtained sequence files were trimmed 
for the constant regions of the adaptor sequences by FASTQ/A Trimmer. The resulting files 
were split into the separate samples according to the barcode sequences in the 3′ end of the 
read by FASTQ/A Barcode splitter. The reads in the resulting files contain 5 random 
nucleotides in the 5′ end and barcoded sequences followed by 5 random nucleotides in the 
3′ end, which were both trimmed by FASTQ/A Trimmer. Extracted reads were mapped by 
Bowtie2 v2.2.4 (default settings) to mouse genome reference sequence (GRCm38/mm10). 
The mapped reads were then intersected with gene annotation (Ensemble GRCm38 release 
91) supplemented with tRNA annotation from the Genomic tRNA Database (Lowe and 
Eddy, 1997). The numbers of mapped reads that overlap with each annotations were counted 
by bedtools coverage. For annotating tRNA fragments, a bed file that contains the 
coordination of different tRF groups, as described in Figure 2C, within 472 annotated tRNAs 
was created. The coverage of tRNA reads in EV or cell samples for different tRF groups 
annotated in this bed file was calculated by bedtools coverage. The tRNA read was assigned 
to a specific tRF group that has the largest coverage by the read. More then 90% of tRNA 
reads were assigned to specific tRFs with more then 70% coverage. tRNA reads were 
annotated as ambigious when their coverage for all tRF groups was less than 70%.
tRF antisense oligonucleotides transfection—Antisense 2′-o-methyl 
oligonucleotides (IDT) were transfected using a Neon transfection kit and device 
(Invitrogen). A total of 5 × 105 T cells that have been stimulated for 1 day were washed two 
times with PBS before suspension in 10 μL of buffer T (Neon kit, Invitrogen). Antisense 
oligos (1 μL of 125 μM) were added to the cell suspension to a final volume of 11 μL and 
mixed. 10 μL of the suspension was electroporated with a Neon electroporation device 
(Invitrogen; 1,600 V, 10 ms, three pulses). The transfected T cells were then cultured in 0.5 
mL media so that the final concentration of tRF antisense oligos is 250 nM. The 0.5 mL 
media for culturing transfected T cells were in 24-well plates with plate-bound anti-CD3 
(2.0 μg/ml), soluble anti-CD28 (0.5 μg/ml) and 10 units/mL IL2. After 2 days of culture, the 
transfected T cells were harvested and analyzed by flow cytometry for surface CD44 and 
CD62L expression. The sequence of antisense oligo for Leu-TAA:5′tRF was 
CCACUCGGCCAUUCUG, for Leu-TAG:5′tRF was CCGCUCGGCCACGCUA, for Ser-
GCT:3′i-tRF was CCCUCGCGUGCAAAGCACA, and for Leu-TAA:3′i-tRF was 
ACGCGGAUAUAAAUCC.
Intracellular cytokine staining—After 2 days of culture, T cells transfected with 
antisense oligos were restimulated for 3 hours with 10 nM PMA and 1 μM Ionomycin in the 
presence of 5 μg/ml brefeldin A. The harvested cells were stained with cell viability dye 
(eFluor 780, Invitrogen) followed by fixation, permeabilization and IL-2 staining as 
previously described (Steiner et al., 2011).
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QUANTIFICATION AND STATISTICAL ANALYSIS
All statistical information pertaining to the number of replicates and significance can be 
found in the figure legends. All experiments were performed at least three times 
independently where possible. In instances where the experiments were performed two times 
due to limited availability of primary cells or reagents, independent techniques were used to 
validate the findings.
RNA-seq data analysis—The ‘Deseq2′ package (Love et al., 2014) was used for 
analysis of differential expression. ‘ggplot2′ was used to produce scatterplots. EV 
enrichment (EE) in Figures 2, 3, and 5 was the fold-change of read counts in EVs versus 
cells. Deseq2 was used for analyzing the fold-changes of all annotated genes in EVs versus 
in cells and then the fold-changes of miRNAs and tRFs were subset from all genes. Thus, 
the EE of miRNAs and tRFs is a relative value that is compared to small RNAs derived from 
all genes. Deseq2 was also used for analyzing the fold-changes of the EE of all annotated 
genes in stimulated versus resting conditions or in stimulated conditions with DMSO versus 
with GW4869. The fold-changes of the EE of tRFs were subset from all genes. Thus, the 
fold-change of the EE of tRFs is also a relative value that is compared to small RNAs 
derived all genes.
DATA AND SOFTWARE AVAILABILITY
RNA sequencing data are deposited at GEO under the accession number GEO: GSE121724.
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Refer to Web version on PubMed Central for supplementary material.
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Highlights
• Specific tRFs are enriched in extracellular vesicles released by T cells
• T cell activating signals regulate tRF secretion
• Activation enhances multivesicular body formation and cellular tRF 
downregulation
• Activation-induced, extracellular-vesicle-enriched tRFs inhibit T cell 
activation
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Figure 1. EVs that Contain Intact Discrete RNA Species Are Separated from Protein Aggregates 
that Are Dominated by Fragmented RNAs
(A) Schematic of a two-step purification procedure for separation of EVs from aggregates in 
cell culture supernatant. The supernatant was first subjected to differential centrifugation to 
remove live cells, dead cells, cell debris, and, finally, EVs, and aggregates were precipitated 
into 100,000 × g pellets. The 100,000 × g pellets were further separated by sucrose gradient 
into 6 fractions.
(B) Western blot (top panel) analysis of sucrose gradient fractions of the separated 100,000 
× g pellets and cell lysates prepared from the indicated numbers of cells in each lane. 
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Bradford assay (bottom panel) determined total protein recovered in each fraction or cell 
lysate. * marks lanes containing similar concentrations of proteins from cell lysates (lane 2) 
and sucrose gradient fraction 3 (lane 7).
(C) RNA 2100 Bioanalyzer analysis of large RNA species (left panel) and PAGE analysis of 
small RNA species ranging from 50 to 300 bp (right panel). Bottom panel shows total RNA 
yield from each fraction. * marks lanes with similar RNA yield from cells (lane 1) and 
sucrose gradient fraction 3 (lane 4).
(D) qPCR analysis of miRNA abundance in equal volumes of RNA purified from each 
fraction.
(E) qPCR analysis of the abundance of the indicated RNA species detected in fraction 3 
(top) or in fraction 6 (bottom) left untreated or treated with RNase A or RNase A and Triton 
X-100.
Data are representative of three independent experiments. Statistical significance is 
measured using a one-tailed t test: *p < 0.05, **p < 0.01, and ***p < 0.001.
Error bars indicate SD of the mean. See also Figure S1.
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Figure 2. Comparing the Composition of Small RNAs in Activated T Cells, EVs, and Aggregates
(A) Relative composition of mapped reads in small RNA libraries. RNA classification was 
based on the biotypes of Ensembl gene and transcript annotation. The “transcript” RNA 
class is the union of different biotypes, including processed transcript, antisense, and 
pseudogene.
(B) Sub-classification of reads shown as “other_RNA” in (A) into tRNA, snoRNA, snRNA, 
and misc_RNA.
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(C) Pictorial summary of the 7 categories of tRFs that can arise from mature tRNAs. 3′i-tRF 
were further classified as hairpin (H) or linear (L) to indicate the presence or absence of 
tRNA variable loop-derived hairpin structures, respectively.
(D) Classification of reads in the 7 tRF classes shown in (C) and rare tRFs of ambiguous 
classification.
(E and F) MA plots comparing EV enrichment (EEs) (ratio of reads in EVs versus cells) and 
mean of normalized counts per million for all 257 detected miRNAs (E, left), all 768 
detected tRFs (E, right), and subsets of tRFs in the indicated classes (F). Dotted lines and 
arrows indicate thresholds at 1.0 (no enrichment) and 1.5 EE. Black circles (·) mark RNA 
species significantly enriched in exosomes (≥ 1.5-fold; adjusted p < 0.05), and the 
percentage of significantly enriched RNA species among each class is indicated in each plot.
See also Figure S2 and Table S1.
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Figure 3. T Cell Activation Induces the EV Enrichment of tRFs that Are Derived from the 5′-
Portion of tRNAs and the 3′-Internal Region of tRNAs without Hairpin Structures
(A) Western blot (top panel) analysis of sucrose gradient fractions of the separated 100,000 
× g pellets and cell lysates prepared from the indicated numbers of cells cultured under 
resting or stimulated conditions. Bradford assay (bottom panel) determined total protein 
recovered in each fraction or cell lysate. * marks lanes containing similar concentrations of 
proteins from cell lysates (lane 4) and EVs (sucrose gradient fraction 3; lane 8).
(B) Chemiluminescent quantification of western blot for proteins as shown in (A), expressed 
as the ratio of each protein in EVs versus cell lysates.
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(C) tRF sequence reads from resting and stimulated cellular and EV small RNA libraries 
classified as in Figures 2C and 2D.
(D) EV enrichment (EE) for the indicated tRF classes from T cells cultured under resting 
(EER, x axis) and stimulated (EES, y axis) conditions. Dotted black lines and arrows indicate 
thresholds at 1.0 EES (no enrichment) and 1.5 EES. Solid black line demarcates equal EE in 
resting and stimulated cells (EES/EER = 1). Red dotted line indicates threshold at 1.5-fold 
increased EE in stimulated cells compared to resting cells (EES/EER ≥ 1.5). tRFs exhibiting 
activation-induced EV enrichment (EEs ≥ 1.5 and EES/EER ≥ 1.5) are marked by red circles 
(adjusted p < 0.05) or pink circles (adjusted p < 0.5). Black circles (·) mark tRFs with 
activation-independent EV enrichment in stimulated cells (EES ≥ 1.5; adjusted p < 0.05). 
The percentage of tRFs with activation-induced EE (union of red and pink circles) among all 
tRFs enriched in EVs in stimulated cells (union of black, red, and pink circles; total number 
indicated in parentheses after tRF class label in each panel) is indicated in each plot.
(E) 3′i-tRF-L (linear) and 3′i-tRF-H (hairpin) subsets of the total 3′i-tRF shown in (D), 
lower left panel.
see also Figure S3 and Table S2.
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Figure 4. Validation of EV Enrichment of tRFs and Their Responses to T Cell Activation
(A) IGV visualization of tRFs of the indicated classes aligned to five representative mature 
tRNAs.
(B) Electrophoretic analysis of products from the exponential phase of amplification in 
oligo(dT) RT-PCR assays for the indicated tRFs. We detected a band of the correct size and 
a larger product ~60 nt longer than 5′tRF or ~30 nt longer than 3′i-tRF, corresponding to 
amplification from full-length (FL) tRNAs.
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(C) Oligo(dT) qRT-PCR measurement of tRF abundance in EVs in resting (black bars) and 
stimulated (gray bars) conditions.
(D) Oligo(dT) qRT-PCR analysis of the indicated RNA species detected in fraction 3 (F3) 
left untreated or treated with RNase A or with RNase A and Triton X-100.
(E) tRF abundance in cells (black bars) and EVs (gray bars) under resting (R) and stimulated 
(S) conditions as determined by stem-loop qRT-PCR.
Data are representative of at least three independent experiments. Statistical significance is 
measured using a one-tailed t test: *p < 0.05, **p < 0.01, and ***p < 0.001. Error bars 
indicate standard deviation of the mean. See also Figure S4.
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Figure 5. nSMase Inhibitor Represses EV Enrichment of Activation-Induced and Activation-
Independent EV-Enriched tRFs
(A) Western blot analysis of sucrose gradient fractions of the separated 100,000 × g pellets 
and cell lysates from T cells stimulated in the presence of DMSO vehicle control or 
GW4869 at the indicated concentrations. Cell lysates were prepared from higher and lower 
amounts of cells, which are labeled as H and L, respectively.
(B) RNA yield from EV fraction (F3).
(C) Chemiluminescent quantification of western blot for proteins as shown in (A).
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(D) EV enrichment (EE) for the indicated tRF classes from T cells stimulated in the 
presence of DMSO (EEDM, x axis) or GW4869 (EEGW, y axis). Dotted black lines indicate 
thresholds at 1.0 EE (no enrichment) in DMSO or GW4869 condition. Solid black line 
demarcates equal EE in each condition (EEDM/EEGW = 1). Red dotted line indicates 
threshold at 0.67-fold decreased EE in stimulated cells treated with GW4869 compared to 
stimulated cells treated with DMSO(EEGW/EEDM ≤ 0.67). tRFs with EE decreased by 
GW4869 treatment (EEGW/EEDM ≤ 0.67) are marked by red circles (adjusted p < 0.05) or 
pink circles (adjusted p < 0.5). The percentage of tRFs with EE decreased EE by GW4869 
treatment (union of red and pink circles) among all tRFs in that class (union of black, red, 
and pink) is indicated in each plot.
(E) Electrophoretic analysis of products from the exponential phase of amplification in 
oligo(dT) RT-PCR assays for the indicated tRFs as in Figure 4B.
(F) Oligo(dT) qRT-PCR measurement of tRF abundance in EVs from cells stimulated with 
DMSO (black bars) and the indicated concentrations of GW4869 (gray bars).
(G) tRF abundance in cells (black bars) and in EVs (gray bars) under resting and stimulated 
conditions as determined by stem-loop qRT-PCR.
Statistical significance is measured using a one-tailed t test: *p < 0.05, **p < 0.01, and ***p 
< 0.001. Error bars indicate SD of the mean.
See also Figure S5 and Table S2.
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Figure 6. nSMase Inhibitor Induced the Accumulation of Activation-Induced EV-Enriched tRFs, 
but Not Activation-Independent EV-Enriched tRFs, within Rab7-Containing MVB 
Compartments
(A) Schematic of subcellular fractionation of T cells. 15,000 × g pellets obtained from 
differential centrifugation of T cell lysates were layered on the top of the Optiprep gradient 
and then centrifuged at 40,000 rpm for 45 min to separate different membrane organelles or 
cytosolic proteins.
(B and C) Western blot analysis of proteins (B) and stem-loop qRT-PCR quantification of 
tRFs in subcellular fractions obtained from resting conditions or activated conditions treated 
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with DMSO or GW4869 (C). For each fraction, RNA concentration is normalized to fraction 
1. In (B) and (C), red lines indicate cytosolic fractions, and red boxes indicate MVB 
fractions.
Data are representative of two independent experiments. Statistical significance is measured 
using a one-tailed t test: *p < 0.05, **p < 0.01, and ***p < 0.001. Error bars indicate 
standard deviation of the mean. See also Figure S6.
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Figure 7. Transfection of Antisense Oligos against tRFs that Are Associated with MVBs in an 
Activation-Induced Manner Enhances T Cell Activation
(A) Representative flow cytometric analysis of CD44 and CD62L expression on the surface 
of CD4+ T cells transfected with antisense oligos complementary to tRFs or water vehicle 
(H2O) control.
(B and C) Quantified frequency of CD62L+ (B) and CD44+ and CD62L+ (C) cells.
(D) Representative flow cytometric analysis of IL-2 intracellular staining of live CD4+ T 
cells restimulated with PMA and ionomycin.
(E) Geometric mean fluorescence intensity of IL-2 staining.
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Data are representative of at least three independent experiments. Statistical significance is 
measured using a one-tailed t test: *p < 0.05, **p < 0.01, and ***p < 0.001. Error bars 
indicate standard deviation of the mean. See also Figure S7.
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KEY RESOURCES TABLE
REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
GW182 Bethyl Laboratories Cat# A302-329A; RRID: AB_1850240
Ago2 (C34C6) Cell Signaling Cat# 2897S; RRID: AB_2054446
Tsg101 (C-2) Santa Cruz Biotechnology Cat# sc-7964; RRID: AB_671392
CD81 (D5O2Q) Cell Signaling Cat# 10037S; RRID: AB_2714207
Arf6 (3A-1) Santa Cruz Biotechnology Cat# sc-7971; RRID: AB_2289810
Transferrin Receptor Abcam Cat# ab84036; RRID: AB_10673794
Beta-actin (AC-74) Sigma Cat# A5316; RRID: AB_476743
Lamp1 Abcam Cat# ab24170; RRID: AB_775978
Rab7 (D95F2) Cell Signaling Cat# 9367S; RRID: AB_1904103
TIA1 (D-9) Santa Cruz Biotechnology Cat# sc-48371; RRID: AB_628358
Rabbit IgG (H+L) Bio-Rad Cat# 170-6515; RRID: AB_11125142
Mouse IgG (H+L) Bio-Rad Cat# 170-6516; RRID: AB_11125547
CD62L-BV605 (MEL-14) Biolegend Cat# 563252; RRID: AB_11125577
CD44-A700 (IM7) eBioscience Cat# 56-0441-80; RRID: AB_494012
IL2-PerCP-Cy5.5 (JES6-5H4) eBioscience Cat# 503821; RRID: AB_961403
Chemicals, Peptides, and Recombinant Proteins
GW4869 Sigma Cat# D1692
StrataClean Resin Agilent Technologies Cat# 400714
Deposited Data
Raw and processed small RNA sequencing data This paper GEO: GSE121724
Experimental Models: Organisms/Strains
C57BL/6 Jackson Laboratory JAX:000664
Oligonucleotides
Leu-TAA-5RF: ACCAGAATGGCCGAGTGGTTA This paper N/A
Leu-TAG-5RF: GGTAGCGTGGCCGAGCGGTC This paper N/A
Leu-TAA-3RF: GGATTTATATCCGCGTGGG This paper N/A
LeuTAA5_FP_2: ACACTCCAGCTGGGACCAGAATGGCCGA This paper N/A
LeuTAA3_FP_2: ACACTCCAGCTGGGTGGATTTATATCCG This paper N/A
LeuTAG5_FP_2: ACACTCCAGCTGGGGGTAGCGTGGCCGA This paper N/A
LeuTAA5_RP_2: CTCAACTGGTGTCGTGGAGTCGGCAATTCAGTTGAGACCACTCG This paper N/A
LeuTAA3_RP_2: CTCAACTGGTGTCGTGGAGTCGGCAATTCAGTTGAGCCACGCGG This paper N/A
LeuTAG5_RP_2: CTCAACTGGTGTCGTGGAGTCGGCAATTCAGTTGAGACCGCTCG This paper N/A
LeuTAA3_Pr_2: 5′- /56-FAM/TTCAGTTGA/ZEN/GCCACGCGG/3IBkFQ/ –3′ This paper N/A
LeuTAG5_Pr_2: 5′- /56-FAM/TTCAGTTGA/ZEN/GACCGCTCG/3IBkFQ/ –3′ This paper N/A
LeuTAA5_Pr_2: 5′- /56-FAM/TTCAGTTGA/ZEN/GACCACTCG/3IBkFQ/ –3′ This paper N/A
Universal RP: GTGTCGTGGAGTCGGC This paper N/A
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REAGENT or RESOURCE SOURCE IDENTIFIER
Software and Algorithms
Bowtie2 v2.2.4 Langmead and Salzberg, 
2012
http://bowtie-bio.sourceforge.net/bowtie2
Samtools v1.7 Li et al., 2009 https://github.com/samtools/samtools
Bedtools v2.27.1 Quinlan and Hall, 2010 https://github.com/arq5x/bedtools2
DEseq2 v1.18.1 Love et al., 2014 https://bioconductor.org/biocLite.R
FASTX-Toolkit v0.0.14 Gregory Hannon lab at 
cold spring harbor 
laboratory
http://hannonlab.cshl.edu/fastx_toolkit
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